Ahmedabad based CRAMS major Dishman Pharmaceuticals & Chemicals has posted a 17.9 per cent rise in net profit in the quarter ended September 30 to Rs 28.29 crore. Net sales during the quarter, however, was down by 2.13 per cent to Rs 212.79 crore from Rs 217.43 crore in the corresponding quarter previous fiscal.
For the first half of the fiscal, the company's net profit was down from Rs 63.14 crore in H1FY10 to Rs 55.54 crore in the first six months this fiscal ending September 30.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app